Related Experiment Video

Updated: Jun 10, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

The treatment of patients with HIV

Martin Vogel1, Carolynne Schwarze-Zander, Jan-Christian Wasmuth

  • 1Medizinische Klinik und Poliklinik I, Universitätsklinikum Bonn.

Deutsches Arzteblatt International
|August 13, 2010
PubMed

Insights

Early human immunodeficiency virus (HIV) testing and timely highly active antiretroviral therapy (HAART) initiation are crucial for patients. Prompt treatment can lead to a near-normal life expectancy for individuals with HIV.

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • Human immunodeficiency virus (HIV) infection presents a significant global health challenge.
  • Despite advancements, a substantial percentage of individuals are diagnosed late, at AIDS or advanced immunodeficiency stages.

Purpose of the Study:

  • To review current guidelines for adult HIV treatment in Germany, Austria, Europe, and the USA.
  • To emphasize the importance of timely diagnosis and treatment initiation for better patient outcomes.

Main Methods:

  • A selective literature review was conducted.
  • Current German/Austrian, European, and American guidelines on HIV treatment were analyzed.

Main Results:

  • Approximately 3000 new HIV infections occur annually in Germany, with 67,000 people living with HIV in 2009.
  • Highly active antiretroviral therapy (HAART) can enable a near-normal life expectancy if started promptly.
  • Treatment decisions must consider drug resistance, comorbidities, and patient circumstances, aiming for HIV-RNA suppression below 50 copies/mL.

Conclusions:

  • HIV testing should be recommended for high-risk individuals and those diagnosed with sexually transmitted diseases.
  • Managing HIV in aging populations requires vigilance for comorbidities and potential drug interactions.
Abstract

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...